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Purpose: The purpose of this report is to describe the proton therapy system at Samsung Medical Center (SMC-PTS) including 
the proton beam generator, irradiation system, patient positioning system, patient position verification system, respiratory gating 
system, and operating and safety control system, and review the current status of the SMC-PTS.
Materials and Methods: The SMC-PTS has a cyclotron (230 MeV) and two treatment rooms: one treatment room is equipped 
with a multi-purpose nozzle and the other treatment room is equipped with a dedicated pencil beam scanning nozzle. The proton 
beam generator including the cyclotron and the energy selection system can lower the energy of protons down to 70 MeV from the 
maximum 230 MeV. 
Results: The multi-purpose nozzle can deliver both wobbling proton beam and active scanning proton beam, and a multi-leaf 
collimator has been installed in the downstream of the nozzle. The dedicated scanning nozzle can deliver active scanning proton 
beam with a helium gas filled pipe minimizing unnecessary interactions with the air in the beam path. The equipment was provided 
by Sumitomo Heavy Industries Ltd., RayStation from RaySearch Laboratories AB is the selected treatment planning system, and data 
management will be handled by the MOSAIQ system from Elekta AB.
Conclusion: The SMC-PTS located in Seoul, Korea, is scheduled to begin treating cancer patients in 2015.
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Introduction
The Samsung Medical Center (SMC) was founded on November 
9, 1994 under the philosophy of “contributing to improving 
the nation’s health through the best medical service, advanced 
medical research, and development of outstanding medical 
personnel.” SMC consists of a hospital and a cancer center; the 
hospital is located in an intelligent building with 20 floors above 
ground and 5 floors underground, housing 40 departments, 
10 specialist centers, and 120 special clinics. The cancer center 
has 11 floors above ground and 8 floors underground. SMC is a 
tertiary hospital manned by approximately 7,400 staff including 
over 1,200 doctors and 2,300 nurses.
The Proton Therapy Center at SMC will be the first private-
hospital based proton therapy center in Korea. Although there 
still exist some debates on the cost-effectiveness of the proton 
therapy, the well-proven superior dosimetric properties of 
the proton therapy leads to an increasing number of proton 
therapy facilities around the world [1].
SMC will introduce the state-of-the-art proton therapy 
system, and by introducing the most advanced radiation 
therapy system, SMC expects improved treatment outcomes 
with minimal toxicity and improved quality of life of patients.
The Proton Therapy Center at SMC is located in a new 
building on the land area of more than 150,000 m2 with floor 
space of more than 14,000 m2 (6 floors above ground and 
4 floors underground). The computed tomography (CT) and 
magnetic resonance imaging devices will be installed in the 
Proton Therapy Center so that both diagnostic imaging and 
proton beam treatment can be conducted in the same building.
After the contract is signed with Sumitomo Heavy Industries 
Ltd. (hereafter SHI), the groundbreaking ceremony of the 
proton therapy center was in October 2011 and the machine 
installation started in May 2013.
The proton therapy system at SMC (SMC-PTS) will have 
distinguished characteristics with the state-of-the-art 
technologies like, image-guided proton therapy with cone-
beam computed tomography, respiratory gated proton therapy, 
accurate patient positioning with a robotic couch, and an 
effective treatment preparation with multi-leaf collimator (MLC).
This report provides an overview of the status of the SMC-
PTS focusing on the major equipment used for the acceleration, 
transport, and delivery of proton beams. The clinical commissioning 
of the SMC-PTS systems, dosimetric measurements and 
calculations will be described in future publications.
Materials and Methods
1. The SMC proton therapy system
1) The overall proton therapy system: The SMC-PTS 
can be divided into following subsystems: the proton beam 
generator, irradiation system, patient positioning system, 
patient position verification system, respiratory gating system, 
and operating and safety control system.
The proton beam generator includes the accelerator, 
energy selection system (ESS), and beam transport system 
(BTS). And the irradiation system is composed of a rotating 
gantry and a nozzle. Each of the treatment rooms has its own 
irradiation system (a multi-purpose nozzle or a dedicated 
scanning nozzle). Details of each subsystem will be described 
in following sections and the layout of the treatment level of 
the Proton Therapy Center at SMC is shown in Fig. 1.
2) Proton beam generator: The proton accelerator at 
SMC-PTS is a normal conducting azimuthally varying field 
(AVF) cyclotron. The magnetic field strength in the cyclotron 
is designed to be radially increasing to correct the increased 
relativistic mass of accelerated protons. At the same time, the 
vertical defocusing of the protons due to the radially increasing 
magnetic field is adjusted by the azimuthally varying magnetic 
field configuration (hill and valley structures). The magnetic 
field of the cyclotron ranged from 0.9 T (valley) to 2.9 T (hill). 
The diameter of the cyclotron is 4.3 m and the weight of the 
cyclotron is approximately 220 tons.
The accelerator is composed of electromagnet system, radio 
frequency (RF) system, ion generator, and beam extractor. The 
electromagnet system generates a magnetic field inside the 
cyclotron and the RF system accelerates protons at a high 
frequency (106 MHz). There are two RF cavities located in the 
Fig. 1. The proton therapy system at Samsung Medical Center 
(SMC-PTC) layout: the layout of the treatment level of the Proton 
Therapy Center at Samsung Medical Center.
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cyclotron. The ion generator ionizes hydrogen gas molecules 
in plasma state and generates protons to be accelerated in the 
cyclotron. In the beam extractor, the deflector applies a high 
voltage to deflect protons toward the outer extraction orbit 
using an electric field. After the deflector, the proton beams 
are focused by a pair of permanent quadrupole magnets. The 
cyclotron accelerates protons up to the energy of 230 MeV.
The ESS is composed of an energy degrader, an energy 
analyzer electromagnet, and a beam diagnosis system. The 
energy of proton beam can be adjusted by the thickness of the 
degrader in the range of 70 MeV to 230 MeV.
Although the extracted proton beams from the cyclotron 
are highly focused by the pair of permanent quadrupole 
magnets in the cyclotron, the energy width and emittance of 
proton beams will be increased by the degrader material. In 
the downstream of the degrader, the ESS composed of a set of 
quadrupole magnets and a bending dipole magnet deflected at 
an angle of 30o is located to re-focus the beam and select the 
proton beams only in the defined energy window by using a 
copper beam slit.
After the ESS and BTS is located to deliver and distribute 
proton beams to each treatment room. The BTS consists of 
a series of quadrupole electromagnets for beam focusing, 
bending dipole magnets for changing beam direction, and 
steering magnets for fine-tuning of the beam paths to the 
treatment rooms. It also includes profile monitors and beam 
current monitors.
3) Irradiation system: Both treatment rooms have isocentric 
gantries, which are rotating steel structures that include the 
irradiation nozzles. The maximum radius of the gantry is 5.3 m 
and the mass of rotating part is 120 tons. The gantry rotates 
±180o with 5o over-travel around the patient with the maximum 
rotation speed of the gantries is 1 rpm. The gantry system has 
the braking system equipped with 6 air-operation brakes. The 
6 brakes assure an emergency stop within 5o at the maximum 
rotation speed.
Treatment nozzles are located at the end of the treatment 
room beam-lines and consist of various components to amend 
beam characteristics for clinical uses. There are two types of 
nozzle systems installed at SMC-PTS: a multi-purpose nozzle 
and a dedicated scanning nozzle. The multi-purpose nozzle 
has both wobbling and scanning function with corresponding 
nozzle components alignment. The dedicated scanning nozzle 
has a helium gas filled pipe, which minimizes unwanted 
interactions of proton beam in the beam path.
Multi-purpose nozzle: The multi-purpose nozzle installed 
at the first gantry room provides both wobbling and scanning 
modes. The components of the multi-purpose nozzle are 
focusing quadrupole magnets, beam profile monitor, wobbling 
(scanning) magnets, scatterers, ridge filters, dose monitor, 
flatness monitor, MLC, a patient-specific compensator, and 
patient collimators as shown in Fig. 2. The beam profile monitor 
in the upstream of the nozzle is inserted in wobbling mode. 
Scatterers and ridge filters will be used only for wobbling 
mode. The maximum field size of the nozzle in wobbling mode 
is 25 cm × 25 cm with MLC retracted (20 cm × 20 cm with 
MLC), and 24 cm × 24 cm in scanning mode. The maximum 
range without a scatterer is 32 g/cm2 and the range can be 
adjusted in steps of 0.1 g/cm2
Dedicated scanning nozzle: The dedicated scanning 
nozzle is installed at the second gantry room with a helium 
gas filled pipe. The maximum field size of the dedicated 
scanning nozzle is 30 cm × 40 cm which is larger than the 
maximum field size of the multi-purpose nozzle. As shown in 
Fig. 3, quadrupole magnets, beam profile monitor, scanning 
magnets, helium gas filled pipe, dose monitor, flatness monitor, 
and optional patient collimator are the main components of 
the dedicated scanning nozzle. As for the dose painting, a line-
scanning method that is faster than spot scanning will be 
implemented in the scanning control system.
4) Patient positioning system and patient position 
verification system: The patient positioning system consists 
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Fig. 2. The multi-purpose nozzle layout: the layout of the 
components in the multi-purpose nozzle. Adapted from Sumitomo 
Heavy Industries Ltd.
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of a robotic couch (Forte Automation Systems Inc., Machesney 
Park, IL, USA) and laser markers. One of the laser markers is 
located on the nozzle so that the center of the proton beam 
flux can be marked. There are additional laser makers located in 
the enclosure (horizontal) and the ceiling (vertical) to mark the 
isocenter. The robotic couch is composed of a table unit and a 
tabletop. The table unit has 6o of freedom and equipped with 
load cells for collision detection and deflection compensation. 
The robotic couch can support the maximum weight of 200 kg.
The VeriSuite (MedCom, Darmstadt, Germany) patient 
position verification system is composed of two orthogonal 
X-ray imaging systems. Each of the X-ray imaging system 
includes an X-ray generator, an X-ray imaging panel, and an 
image-processing device. Neither of the X-ray imaging axes are 
aligned with the proton beam axis as the X-ray imaging beam 
axis is off by 45o from the beam axis. The VeriSuite system can 
be operated in 3 different image acquisition modes: digital 
radiography (DR), fluoroscopy with respiratory signals, and 
cone beam computed tomography (CBCT). The acquired images 
will be compared with planning CT images and a correction 
vector will be calculated for a precise patient positioning.
5) Respiratory gating system: At SMC-PTS, AZ-733V 
(Anzai Medical, Tokyo, Japan) system is installed for gating 
of a respiratory motion. The system is mainly composed of a 
respiratory sensor (RS), a sensor port (SP), and a wave deck 
(WD). The RS detects abdominal motions (pressure changes) 
of a patient and the SP amplifies and transmits the analog 
signal from RS. The WD receives the signal from the SP and 
converts the signal to digital so that it can be sent to a personal 
computer.
The respiratory gating system should be installed not 
only in the irradiation system but also in the simulation CT 
system in order to take images synchronously with a patient’s 
respiration. An identical AZ-733V respiratory gating system 
will be implemented in Discovery CT590 RT (GE Healthcare, 
Milwaukee, WI, USA) located in the simulation room.
6) Operating and safety control system: As the proton 
therapy system is composed of many different devices, the 
control of the whole system can be more efficient if the 
system is segmented into several groups. The segmentation 
can be performed according to function, procedures, and 
location. At SMC, the proton therapy system is mainly divided 
into two groups: the accelerator group and the treatment 
group. The accelerator group includes the proton beam 
accelerator, the ESS, and BTS. The treatment group includes 
the irradiation system, the patient positioning system, and 
the patient position verification system. Two groups meet at 
the exit of the bending magnet in the gantry. The operation of 
two groups is physically separated at different locations, the 
accelerator control room and the treatment control room.
The main control system is composed of encoders connected 
via a network to control both groups. Under normal operation, 
oncology information system is in operation connected with 
the control system.
A treatment safety unit is connected to each control unit 
of the proton therapy system via DeviceNet network, and the 
treatment safety unit is also connected to the door interlock 
system, the emergency stop buttons, and the radiation dose 
monitor system. The treatment safety unit controls overall 
safety of the system operation.
2. Monte Carlo simulation
We have used TOol for PArticle Simulation (TOPAS) for the 
Monte Carlo simulation of the treatment nozzle system. TOPAS 
[2] has been developed mainly for the Monte Carlo simulation 
of particle therapy nozzles based on Geant4 framework [3]. 
Participating in the α-version development, SMC has developed 
the model of SHI system and the developed modules (generic 
MLC and ridge filter) have been included in TOPAS package. 
The specific geometry of treatment nozzles has been provided 
by SHI in the agreement of using the developed Monte Carlo 
simulation in commissioning.
The detailed description of the Monte Carlo modeling of 
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Fig. 3. The dedicated scanning nozzle layout: the layout of the 
components in the dedicated scanning nozzle. Adapted from 
Sumitomo Heavy Industries Ltd.
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the nozzles using TOPAS is available elsewhere [4]. The main 
goal of the Monte Carlo modeling of the treatment nozzles 
is to expedite the commissioning process of the nozzles by 
interpolating or extrapolating measured beam data with 
Monte Carlo simulation results. An example of the spread-out 
Bragg peak (SOBP) curves generated by TOPAS simulation is 
shown in Fig. 4.
And independently, Monte Carlo modeling of the treatment 
nozzles have been developed using Geant4 and MCNP. The 
original purpose in each simulation package was different (e.g., 
the nozzle model using MCNP was developed to study neutron 
dose for real time image guided proton therapy [5]) but they 
can be used as a validation tool for each other.
We will extend applications of developed Monte Carlo 
simulation models to researches on non-beam performance 
of the nozzles and design studies of nozzle elements in the 
future.
Results
1. Status
The installation of proton therapy system has been finished in 
2014. Since then, SHI engineers have conducted an intensive 
machine tuning of the proton therapy system. For a certain 
period of time, the proton therapy system is under machine 
commissioning phase and we have planned mock-up treatments 
as a clinical commissioning of the proton therapy system 
following the completion of the machine commissioning.
The beam data measurement for the modeling of treatment 
planning system started in March 2015. SMC has selected 
RayStation (RaySearch Laboratories AB, Stockholm, Sweden) 
as proton treatment planning system. RayStation is one of 
the most advanced proton treatment planning system with 
distinguished features like, robust optimization, pencil beam 
algorithm with graphics processing unit (GPU) support, 
scripting support, robust planning, etc. It will support SHI’s 
beam delivery techniques.
We have been collecting the beam data according to the 
required beam data list from RaySearch Laboratories AB. The 
measured beam data will be used for the beam modeling of 
RayStation. 
1) Proton beam specifications including beam penumbra, 
distal fall-off width, dose uniformity, SOBP width, maximum 
dose rate, etc.: Based on the early beam data measurements, 
selected proton beam specifications can be described as 
following: the maximum range in G1 wobbling nozzle is 
varying with difference field size configurations (LARGE, 
MIDDLE, and SMALL) as the optimized total thickness of 
scatterers depends on the field size. The minimum range in the 
LARGE field configuration is measured to be 25.7 mm and the 
maximum range in the SMALL field configuration is measured 
to be 308.8 mm. The lateral penumbra (80% to 20%) at the 
middle of SOBP is also a function of the field size, beam energy, 
and the ridge filter selection. In the beam data measurement 
set, the minimum value of the lateral penumbra is achieved 
to 3.26 mm (70 MeV, SMALL, 1 cm ridge filter). The distal fall-
off (distal 80% to 20%) is also a function of the beam energy, 
field size, and the ridge filter selection. The measured distal 
fall-off values are in the range of 1.2 mm to 6.8 mm. The dose 
uniformity in the lateral direction has been verified to be within 
2% (80% of the field size region). The dose uniformity in the 
depth direction has less physical meaning as a single physical 
ridge filter covers a certain energy range: a slight slope in the 
depth direction cannot be avoided unless it is used with the 
optimal condition. The average dose rate in G1 wobbling nozzle 
is verified to be greater than 2 Gy/min for 1-liter volume (above 
110 MeV). More detailed dosimetric characteristics of SMC-PTS 
will be reported in a separate article in the future. 
2) Expected patient setup accuracy with the delivered 
treatment room system: The angular accuracy of gantry 
rotation is less than 0.2o and the positional accuracy of isocenter 
of G1 wobbling nozzle is less than 1 mm. The positional 
accuracy of the robotic couch has been meticulously tested and 
it is below 1 mm. The laser alignment system has been adjusted 
to the DR system within 0.2 mm accuracy. The simple quadratic 
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sum of these uncertainties yields a total uncertainty of 1.4 mm 
and this is a conservative estimation as the correlation among 
the items has been ignored. In addition to the orthogonal X-ray 
imaging system, CBCT was integrated in to the gantry, therefore 
the setup using the internal landmark more relevant to target 
position will be possible.
For oncology information system, SMC made a choice on 
MOSAIQ (Elekta AB, Stockholm, Sweden) based on following 
requirements; support of SHI’s beam delivery information, 
RayStation planning information, SMC Hospital Information 
System (HIS) and oncology communication, remote access 
(open network), integration of IGRT for proton, and integrated 
plan-comparison functionality.
The installation of MOSAIQ system and the first integration 
test with Sumitomo treatment control system (TCS) have 
been finished in March 2015. The final integration test among 
RayStation, MOSAIQ, and Sumitomo TCS will be coming soon.
3) Staffing for running of the proton therapy center: 
According to the original proton project, there will be 6 
physician staff dedicated to the proton therapy at the 
beginning. The number of medical physicists has been gradually 
increased up to 10 since the ground breaking. The engineering 
team has also grown up to 5. In each treatment room, CT 
simulation room, and the machine shop, 2 radiation therapists 
will be assigned. One biologist has joined the project and 
started to work on researches related to the proton therapy.
The volume of staffing will be related to the volume of 
proton therapy patient as well as the stage of the project. 
Up to starting of patient treatment, the physicists staff have 
been gradually increased for beam commission. In the clinical 
commissioning stage at least two medical doctors dedicates to 
proton therapy are required.
For therapist, assigning more than 2 radiation therapists 
for each treatment room is necessary due to the complexity of 
patient positioning and proton beam delivery.
4) Plan for indications of the proton therapy: At the 
beginning, focus of the clinical indications of the proton 
therapy will follow an evidence-based approach: the tumor 
sites demanding a better dose conformality while the tumor 
is contiguous to critical structures, pediatric cancers, and so 
on. The comparison studies with IMRT for all candidate disease 
sites are currently going on.
Discussion and Conclusion
We have described the SMC-PTS and reviewed the current 
status of the project overall. Two rotating gantry rooms with 
a multi-purpose nozzle and a dedicated pencil beam scanning 
nozzle will be used for the proton beam therapy of cancer 
patients at SMC-PTS. It will be capable of treating over than 
480 new patients per year under 8-hour daily operation.
A clinical commissioning following the machine commissioning 
will be intensively conducted with mock-up treatments for 
each clinical case thoroughly and it will guarantee a precise and 
accurate proton beam treatment at SMC-PTS.
Along with the clinical commissioning, we will measure 
relative biological effectiveness (RBE) values with various 
conditions for proton beam at SMC. Although a universal RBE 
of 1.1 has been widely used in clinical proton beam therapy 
[6], a recent study indicated that a fixed RBE is not ideal for 
proton treatment planning [7]. The RBE varies with different 
parameters such as linear energy transfer, dose per fraction, 
and tissue type. With the RBE measurement at SMC-PTS, 
further study of RBE-based proton treatment planning can be 
carried on.
With all the machine and clinical commissioning, we are 
working toward a successful launching of the first private-
hospital based proton therapy center in Korea on schedule to 
be operational in 2015.
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